Page last updated: 2024-11-02

4-phenylbutyric acid and Pancreatic Neoplasms

4-phenylbutyric acid has been researched along with Pancreatic Neoplasms in 4 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research Excerpts

ExcerptRelevanceReference
"Pancreatic beta cell destruction in type 1 diabetes may be mediated by cytokines such as IL-1β, IFN-γ and TNF-α."1.38Cross-talk between the unfolded protein response and nuclear factor-κB signalling pathways regulates cytokine-mediated beta cell death in MIN6 cells and isolated mouse islets. ( Biden, TJ; Chan, JY; Laybutt, DR, 2012)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Welsch, L1
Welsch, T1
Dovzhanskiy, DI2
Felix, K2
Giese, NA1
Krysko, DV2
Werner, J2
Chan, JY1
Biden, TJ1
Laybutt, DR1
Hartwig, W1
Lázár, NG1
Schmidt, A1
Straub, BK1
Hackert, T1
Ammerpohl, O1
Trauzold, A1
Schniewind, B1
Griep, U1
Pilarsky, C1
Grutzmann, R1
Saeger, HD1
Janssen, O1
Sipos, B1
Kloppel, G1
Kalthoff, H1

Other Studies

4 other studies available for 4-phenylbutyric acid and Pancreatic Neoplasms

ArticleYear
Impact of the histone deacetylase inhibitor 4-phenylbutyrate on the clearance of apoptotic pancreatic carcinoma cells by human macrophages.
    International journal of oncology, 2012, Volume: 40, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cel

2012
Cross-talk between the unfolded protein response and nuclear factor-κB signalling pathways regulates cytokine-mediated beta cell death in MIN6 cells and isolated mouse islets.
    Diabetologia, 2012, Volume: 55, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Cytokines; Diabetes Mel

2012
Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of Connexin 43.
    Oncology research, 2012, Volume: 20, Issue:2-3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Proliferation; Connexin 43; Fluorescent Anti

2012
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.
    British journal of cancer, 2007, Jan-15, Volume: 96, Issue:1

    Topics: Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal

2007